Cardiovascular risks with azithromycin and other antibacterial drugs

N Engl J Med. 2013 May 2;368(18):1665-8. doi: 10.1056/NEJMp1302726.

Authors

Andrew D Mosholder¹, Justin Mathew, John J Alexander, Harry Smith, Sumathi Nambiar

Affiliation

¹ Office of Surveillance and Epidemiology, Division of Epidemiology II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

PMID: 23635046
DOI: 10.1056/NEJMp1302726

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents / adverse effects*
Azithromycin / adverse effects*
Cardiovascular Diseases / mortality*
Death, Sudden, Cardiac / etiology*
Female
Humans
Male
Penicillin V / adverse effects*

Substances

Anti-Bacterial Agents
Azithromycin
Penicillin V